We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKD icon
8801
PUT
Brookdale Senior Living
BKD
$3.4B
$195K ﹤0.01%
30,900
+14,200
+85% +$101K
UAVS icon
8802
CALL
AgEagle Aerial Systems
UAVS
$53.9M
$195K ﹤0.01%
65
-152
-70% -$565K
CELC icon
8803
Celcuity
CELC
$4.52B
$194K ﹤0.01%
10,796
+2,167
+25% +$46K
ESPR
8804
DELISTED
Esperion Therapeutics
ESPR
$194K ﹤0.01%
+16,072
New +$234K
NRDY.WS
8805
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$194K ﹤0.01%
+92,786
New +$204K
HEXO
8806
DELISTED
HEXO Corp. Common Shares
HEXO
$194K ﹤0.01%
7,512
-3,112
-29% -$144K
DXD icon
8807
CALL
ProShares UltraShort Dow 30
DXD
$42.2M
$193K ﹤0.01%
+4,040
New +$183K
EVER icon
8808
PUT
EverQuote
EVER
$906M
$192K ﹤0.01%
+10,300
New +$246K
KNSA icon
8809
CALL
Kiniksa Pharmaceuticals
KNSA
$5.93B
$192K ﹤0.01%
+16,900
New +$220K
SPNT icon
8810
SiriusPoint
SPNT
$2.68B
$192K ﹤0.01%
20,694
-16,130
-44% -$155K
VKTX icon
8811
Viking Therapeutics
VKTX
$4B
$192K ﹤0.01%
+30,537
New +$189K
DBD
8812
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
$192K ﹤0.01%
19,000
-18,200
-49% -$200K
SEAH
8813
CALL
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
$192K ﹤0.01%
19,200
-26,600
-58% -$265K
DMYI.WS
8814
DELISTED
dMY Technology Group, Inc. III Redeemable warrants, each whole warrant exercisable for one share of
DMYI.WS
$192K ﹤0.01%
55,554
+1,037
+2% +$2.9K
CLBK icon
8815
Columbia Financial
CLBK
$1.13B
$191K ﹤0.01%
10,344
-11,291
-52% -$202K
TDAY
8816
PUT
USA Today Co
TDAY
$1.06B
$191K ﹤0.01%
28,600
-36,400
-56% -$214K
LXRX icon
8817
Lexicon Pharmaceuticals
LXRX
$1.1B
$191K ﹤0.01%
39,720
+24,509
+161% +$101K
ZIVO
8818
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$191K ﹤0.01%
+6,989
New +$153K
CERS icon
8819
CALL
Cerus
CERS
$474M
$190K ﹤0.01%
31,200
-36,500
-54% -$213K
KALV
8820
PUT
DELISTED
KalVista Pharmaceuticals
KALV
$190K ﹤0.01%
10,900
-2,700
-20% -$54.7K
KNDI
8821
PUT
Kandi Technologies Group
KNDI
$65.5M
$190K ﹤0.01%
42,600
-65,700
-61% -$332K
RC
8822
Ready Capital
RC
$308M
$189K ﹤0.01%
13,076
+2,585
+25% +$39.2K
SRGA
8823
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$189K ﹤0.01%
+5,791
New +$212K
DAO
8824
Youdao
DAO
$2.19B
$188K ﹤0.01%
+15,544
New +$212K
GILT icon
8825
Gilat Satellite Networks
GILT
$848M
$188K ﹤0.01%
20,859
-45,586
-69% -$446K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.